Aspire Biopharma Inc.

NASDAQ: ASBP · Real-Time Price · USD
0.23
0.00 (1.28%)
At close: May 23, 2025, 3:59 PM
0.23
0.83%
After-hours: May 23, 2025, 05:37 PM EDT

Company Description

Aspire Biopharma Holdings, Inc. is a biotechnology company specializing in advanced diagnostic solutions and molecular testing.

The company focuses on developing high-precision assays for disease detection, leveraging cutting-edge research in genetics and biochemistry to support healthcare and life sciences industries.

Aspire Biopharma Inc.
Aspire Biopharma  Inc. logo
Country United States
IPO Date Apr 11, 2022
Industry Biotechnology
Sector Healthcare
Employees 2
CEO Kraig T. Higginson

Contact Details

Address:
188 Grand Street, Unit 195
Humacao, New York
United States
Website https://aspirebiolabs.com/

Stock Details

Ticker Symbol ASBP
Exchange NASDAQ
Fiscal Year n/a
Reporting Currency USD
CIK Code n/a
CUSIP Number 738920107
ISIN Number US7389201077
Employer ID -
SIC Code n/a

Key Executives

Name Position
Kraig T. Higginson President, Chief Executive Officer & Chairman of Board
Ernest J. Scheidemann Jr. Chief Financial Officer
Stephen E. Quesenberry General Counsel & Corporate Secretary

Latest SEC Filings

No SEC filings available.